Abstract
Inflammatory breast cancer (IBC) presents with unique clinical characteristics (erythema, warming, peau d'orange), rapid progression, and poor survival compared to non-IBC breast cancers. Modern combined modality treatment has significantly improved overall survival. However, IBC treatment remains a major challenge. Recently, rapid progress has been made in the molecular characterization of IBC. In this review, we discuss the current advances in understanding the genetic determinants of IBC with emphasis on their present and potential applications to diagnosis, prognosis, and treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
